All 63 PILL (DIREXION DAILY PHARMACEUTICAL & MEDICAL BULL 3X SHARES) Holdings
There are 63 PILL holdings. Top 10 companies weight: 54.10%.
Total Market Cap: $2.28T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (63 stocks) | +16.40% | 25.59 | 19.33 | 0.29 | +16.25% | +21.43% | 0.45 | ||||||||||
1 | n/a | Goldman Finl Sq Trsry Inst 506 | 18.24% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | n/a | Dreyfus Govt Cash Man Ins | 11.38% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | n/a | S&p Pharmaceuticals Select Index Swap | 10.72% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | n/a | Goldman Sachs Fin Gov 465 Institut | 2.68% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | OGN | Organon & Co Ordinary Shares | 2.43% | $13.38 | $3.51B | Drug Manufacturers - General | Healthcare | -35.81% | 14.21 | 5.09 | N/A | N/A | N/A | 40 | -15.92% | $11 | -15.01% | 0.87 |
6 | CORT | Corcept Therapeutics Inc | 2.07% | $71.20 | $6.96B | Biotechnology | Healthcare | -8.23% | 158.39 | 85.47 | 0.81 | N/A | N/A | N/A | N/A | N/A | +26.78% | N/A |
7 | LQDA | Liquidia Corp Ordinary Shares | 1.80% | $55.11 | $5.48B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 257.84 | 28.33 | N/A | N/A | N/A | 72 | +18.16% | $65 | +79.11% | 1.13 |
8 | AXSM | Axsome Therapeutics Inc | 1.70% | $222.16 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +21.66% | $270 | +29.20% | 0.68 |
9 | ELVN | Enliven Therapeutics Inc | 1.60% | $35.52 | $2.52B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +60.47% | $57 | +1.63% | 1.23 |
10 | JAZZ | Jazz Pharmaceuticals Plc | 1.48% | $226.12 | $15B | Biotechnology | Healthcare | N/A | N/A | 12.69 | 0.99 | N/A | N/A | 78 | +11.98% | $253 | +5.45% | 0.73 |
11 | DFTX | N/A | 1.42% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | TRVI | Trevi Therapeutics Inc | 1.39% | $13.50 | $1.86B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 79 | +77.04% | $24 | +43.35% | 0.64 |
13 | VTRS | Viatris Inc | 1.35% | $15.69 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 6.41 | 0.14 | N/A | N/A | 61 | +15.11% | $18 | +4.66% | 0.80 |
14 | ESPR | Esperion Therapeutics Inc | 1.34% | $3.14 | $787M | Drug Manufacturers - Specialty & Generic | Healthcare | -31.57% | N/A | 4.64 | N/A | N/A | N/A | N/A | N/A | N/A | -31.73% | N/A |
15 | RPRX | Royalty Pharma Plc Class A | 1.34% | $54.01 | $24B | Biotechnology | Healthcare | N/A | 27.50 | 46.08 | 1.27 | N/A | N/A | 75 | +9.70% | $59 | +6.80% | 0.28 |
16 | INDV | N/A | 1.33% | $33.71 | $4.60B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 23.54 | 11.38 | N/A | N/A | N/A | 79 | +52.77% | $52 | +25.39% | 0.72 |
17 | PRGO | Perrigo Co Plc | 1.27% | $10.46 | $1.54B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 5.08 | N/A | N/A | N/A | 65 | +57.74% | $17 | -22.80% | 0.76 |
18 | EWTX | Edgewise Therapeutics Inc | 1.25% | $37.25 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +18.58% | $44 | +7.36% | 1.37 |
19 | MBX | Mbx Biosciences Inc | 1.25% | $30.70 | $1.52B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +125.05% | $69 | 0.00% | 1.46 |
20 | PCRX | Pacira Biosciences Inc | 1.24% | $22.25 | $945M | Drug Manufacturers - Specialty & Generic | Healthcare | -47.75% | 181.48 | 7.93 | 11.21 | N/A | N/A | 60 | +31.64% | $29 | -18.58% | 0.32 |
21 | ANIP | Ani Pharmaceuticals Inc | 1.24% | $74.65 | $1.71B | Drug Manufacturers - Specialty & Generic | Healthcare | +25.74% | 20.61 | 9.51 | 0.01 | N/A | N/A | 81 | +47.19% | $110 | +16.83% | 0.64 |
22 | LGND | Ligand Pharmaceuticals Inc | 1.23% | $232.76 | $4.72B | Biotechnology | Healthcare | +26.59% | 30.19 | 25.77 | 1.53 | N/A | N/A | 80 | +19.26% | $278 | +15.54% | 1.02 |
23 | LLY | Eli Lilly And Co | 1.22% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
24 | HRMY | N/A | 1.21% | $30.91 | $1.78B | Biotechnology | Healthcare | N/A | 12.18 | 10.08 | N/A | N/A | N/A | 63 | +43.51% | $44 | -1.26% | 0.69 |
25 | XERS | Xeris Biopharma Holdings Inc | 1.20% | $6 | $1.08B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 87.25 | 75.76 | N/A | N/A | N/A | 75 | +88.17% | $11 | +9.28% | 1.08 |
26 | MRK | Merck & Co Inc | 1.19% | $115.70 | $297B | Drug Manufacturers - General | Healthcare | +4.39% | 27.45 | 22.78 | 5.59 | N/A | N/A | 69 | +12.13% | $130 | +12.86% | 0.32 |
27 | NUVB | N/A | 1.18% | $4.90 | $1.64B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +151.63% | $12 | -18.26% | 1.49 |
28 | AMRX | N/A | 1.17% | $12.65 | $4.04B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 40.55 | 6.30 | N/A | N/A | N/A | 85 | +35.97% | $17 | +18.00% | 0.97 |
29 | INVA | Innoviva Inc | 1.17% | $21.35 | $1.63B | Biotechnology | Healthcare | +16.74% | 3.19 | 11.12 | 0.33 | N/A | N/A | 62 | +66.28% | $36 | +10.06% | 0.22 |
30 | CRNX | Crinetics Pharmaceuticals Inc | 1.15% | $32.61 | $3.87B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +13.39% | N/A |
31 | ELAN | Elanco Animal Health Inc | 1.13% | $23.66 | $12B | Drug Manufacturers - Specialty & Generic | Healthcare | -17.32% | N/A | 18.94 | 4.04 | N/A | N/A | 77 | +25.94% | $30 | -7.54% | 1.31 |
32 | OMER | Omeros Corp | 1.13% | $10.26 | $797M | Biotechnology | Healthcare | N/A | 9.88 | 58.14 | 0.81 | N/A | N/A | 62 | +289.86% | $40 | -8.66% | 1.33 |
33 | BMY | Bristol-myers Squibb Co | 1.12% | $54.46 | $117B | Drug Manufacturers - General | Healthcare | +5.08% | 13.54 | 9.06 | 183.93 | N/A | N/A | 61 | +15.83% | $63 | +0.55% | 0.26 |
34 | PFE | Pfizer Inc | 1.10% | $25.55 | $149B | Drug Manufacturers - General | Healthcare | -6.35% | 12.31 | 8.73 | 0.09 | N/A | N/A | 56 | +14.25% | $29 | -3.24% | 0.40 |
35 | JNJ | Johnson & Johnson | 1.10% | $222.89 | $557B | Drug Manufacturers - General | Healthcare | +11.59% | 20.68 | 19.49 | 3.01 | N/A | N/A | 68 | +13.45% | $253 | +9.09% | 0.01 |
36 | COLL | Collegium Pharmaceutical Inc | 1.10% | $30.48 | $1.09B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 36.96 | 4.28 | N/A | N/A | N/A | 79 | +78.25% | $54 | +6.28% | 0.54 |
37 | HROW | Harrow Inc | 1.07% | $32.86 | $1.28B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 232.56 | N/A | N/A | N/A | 75 | +106.18% | $68 | +28.74% | 1.78 |
38 | AMLX | Amylyx Pharmaceuticals Inc | 1.06% | $13.29 | $1.56B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +76.07% | $23 | 0.00% | 1.15 |
39 | RAPP | Rapport Therapeutics Inc | 1.05% | $34.90 | $1.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +63.61% | $57 | 0.00% | 1.35 |
40 | SUPN | Supernus Pharmaceuticals Inc | 1.04% | $44.07 | $2.71B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +42.57% | $63 | +8.17% | 0.51 |
41 | EYPT | Eyepoint Inc | 1.04% | $12.53 | $1.10B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 80 | +195.29% | $37 | +6.37% | 1.30 |
42 | NKTR | Nektar Therapeutics | 1.04% | $58.56 | $1.62B | Biotechnology | Healthcare | -24.01% | N/A | 34.01 | 0.31 | N/A | N/A | 75 | +161.70% | $153 | -26.23% | 1.86 |
43 | OCUL | Ocular Therapeutix Inc | 1.01% | $8.31 | $1.87B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +212.88% | $26 | -10.44% | 1.35 |
44 | TARS | N/A | 1.01% | $57.41 | $2.58B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +63.93% | $94 | +11.68% | 0.65 |
45 | ALMS | Alumis Inc | 0.98% | $20.04 | $2.67B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +100.10% | $40 | 0.00% | 0.84 |
46 | CRMD | Cormedix Inc | 0.90% | $8.17 | $663M | Biotechnology | Healthcare | N/A | 3.65 | 16.56 | N/A | N/A | N/A | N/A | N/A | N/A | +2.31% | N/A |
47 | TBPH | Theravance Biopharma Inc | 0.87% | $15.58 | $838M | Biotechnology | Healthcare | N/A | 11.78 | 7.45 | N/A | N/A | N/A | 62 | +11.68% | $17 | -1.45% | 0.58 |
48 | PHAT | N/A | 0.87% | $9.65 | $853M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +145.60% | $24 | -21.89% | 1.31 |
49 | PBH | Prestige Consumer Healthcare Inc | 0.86% | $45.83 | $2.34B | Drug Manufacturers - Specialty & Generic | Healthcare | +8.18% | 12.35 | 10.24 | 1.46 | N/A | N/A | 67 | +45.76% | $67 | -1.87% | 0.45 |
50 | AMPH | Amphastar Pharmaceuticals Inc | 0.84% | $18.45 | $853M | Drug Manufacturers - Specialty & Generic | Healthcare | +101.37% | 11.10 | N/A | 2.77 | N/A | N/A | 60 | +26.45% | $23 | -0.23% | 0.80 |
PILL (DIREXION DAILY PHARMACEUTICAL & MEDICAL BULL 3X SHARES) Sector Allocation
HEALTHCARE
63.10%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%